Prognostic value of claudin 18.2 expression in gastric adenocarcinoma

Table 2 Univariate and multivariate analysis of baseline characteristics for progression-free survival

Parameter	Progression-free survival univariate analysis				Progression-free survival multivariate analysis
	HR	95%CI	P		HR	95%CI	P
Age in yr	1.36	0.80-2.30	0.26	Age in yr	1.29	0.71-2.33	0.41
Sex	1.40	0.76-2.56	0.28	Sex	1.49	0.73-3.05	0.28
Lauren classification	0.89	0.52-1.53	0.67	Lauren classification	0.93	0.39-2.22	0.87
Tumor grade	0.85	0.49-1.47	0.56	Tumor grade	0.91	0.58-1.43	0.69
Family history	0.87	0.45-1.77	0.75	Family history	0.51	0.20-1.28	0.15
Liver metastasis	1.09	0.64-1.85	0.75	Liver metastasis	1.07	0.60-1.91	0.82
Lung metastasis	0.93	0.52-1.66	0.79	Lung metastasis	0.98	0.49-1.94	0.95
Localization	0.94	0.42-2.11	0.88	Localization	1.01	0.81-1.24	0.98
Metastasis sites	0.83	0.27-2.60	0.75	Metastasis sites	0.99	0.84-1.18	0.94
Her2Neu	0.81	0.40-1.64	0.56	Her2Neu	0.85	0.37-1.93	0.69
CLDN18.2	1.22	0.54-2.32	0.77	CLDN18.2	1.30	0.54-3.19	0.56

CI: Confidence interval; CLDN18.2: Claudin 18.2; HR: Hazard ratio.